•
Dec 31, 2015

Jazz Pharmaceuticals Q4 2015 Earnings Report

Total Revenue
$341M
Previous year: $328M
+3.9%
EPS
$2.6
Previous year: $2.44
+6.6%
Gross Profit
$317M
Previous year: $299M
+5.9%
Cash and Equivalents
$989M
Previous year: $684M
+44.6%
Total Assets
$3.33B
Previous year: $3.34B
-0.2%

Jazz Pharmaceuticals

Jazz Pharmaceuticals